NeoGenomics to Present at the Wall Street Analyst Forum on November 28, 2007
About NeoGenomics, Inc.
NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratorythat specializes in cancer genetics diagnostic testing, the fastest growingsegment of the laboratory industry. The company's testing services includecytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry,morphology studies, anatomic pathology and molecular genetic testing.Headquartered in Fort Myers, FL, NeoGenomics has labs in Nashville, TN,Irvine, CA and Fort Myers and services the needs of pathologists, oncologists,urologists, hospitals and other reference laboratories throughout the UnitedStates. For additional information about NeoGenomics, visithttp://www.neogenomics.org.
Interested parties can also access additional investor relations materialfrom the American Microcap Institute athttp://www.americanmicrocapinstitute.com/ngnm/ or from Hawk Associates athttp://www.hawkassociates.com. An investment profile about NeoGenomics may befound at http://www.hawkassociates.com/ngnmprofile.aspx.
SOURCE NeoGenomics, Inc.
You May Also Like